BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

361 related articles for article (PubMed ID: 25765123)

  • 1. Dominant frontotemporal dementia mutations in 140 cases of primary progressive aphasia and speech apraxia.
    Flanagan EP; Baker MC; Perkerson RB; Duffy JR; Strand EA; Whitwell JL; Machulda MM; Rademakers R; Josephs KA
    Dement Geriatr Cogn Disord; 2015; 39(5-6):281-6. PubMed ID: 25765123
    [TBL] [Abstract][Full Text] [Related]  

  • 2. GRN and MAPT Mutations in 2 Frontotemporal Dementia Research Centers in Brazil.
    Takada LT; Bahia VS; Guimarães HC; Costa TV; Vale TC; Rodriguez RD; Porto FH; Machado JC; Beato RG; Cesar KG; Smid J; Nascimento CF; Grinberg LT; Brucki SM; Maximino JR; Camargos ST; Chadi G; Caramelli P; Nitrini R
    Alzheimer Dis Assoc Disord; 2016; 30(4):310-317. PubMed ID: 27082848
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Analyses MAPT, GRN, and C9orf72 mutations in Chinese patients with frontotemporal dementia.
    Tang M; Gu X; Wei J; Jiao B; Zhou L; Zhou Y; Weng L; Yan X; Tang B; Xu J; Shen L
    Neurobiol Aging; 2016 Oct; 46():235.e11-5. PubMed ID: 27311648
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum neurofilament light chain protein is a measure of disease intensity in frontotemporal dementia.
    Rohrer JD; Woollacott IO; Dick KM; Brotherhood E; Gordon E; Fellows A; Toombs J; Druyeh R; Cardoso MJ; Ourselin S; Nicholas JM; Norgren N; Mead S; Andreasson U; Blennow K; Schott JM; Fox NC; Warren JD; Zetterberg H
    Neurology; 2016 Sep; 87(13):1329-36. PubMed ID: 27581216
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Primary Progressive Aphasia Associated With
    Saracino D; Ferrieux S; Noguès-Lassiaille M; Houot M; Funkiewiez A; Sellami L; Deramecourt V; Pasquier F; Couratier P; Pariente J; Géraudie A; Epelbaum S; Wallon D; Hannequin D; Martinaud O; Clot F; Camuzat A; Bottani S; Rinaldi D; Auriacombe S; Sarazin M; Didic M; Boutoleau-Bretonnière C; Thauvin-Robinet C; Lagarde J; Roué-Jagot C; Sellal F; Gabelle A; Etcharry-Bouyx F; Morin A; Coppola C; Levy R; Dubois B; Brice A; Colliot O; Gorno-Tempini ML; Teichmann M; Migliaccio R; Le Ber I;
    Neurology; 2021 Jul; 97(1):e88-e102. PubMed ID: 33980708
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Brain atrophy over time in genetic and sporadic frontotemporal dementia: a study of 198 serial magnetic resonance images.
    Whitwell JL; Boeve BF; Weigand SD; Senjem ML; Gunter JL; Baker MC; DeJesus-Hernandez M; Knopman DS; Wszolek ZK; Petersen RC; Rademakers R; Jack CR; Josephs KA
    Eur J Neurol; 2015 May; 22(5):745-52. PubMed ID: 25683866
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical and genetic analysis of MAPT, GRN, and C9orf72 genes in Korean patients with frontotemporal dementia.
    Kim EJ; Kwon JC; Park KH; Park KW; Lee JH; Choi SH; Jeong JH; Kim BC; Yoon SJ; Yoon YC; Kim S; Park KC; Choi BO; Na DL; Ki CS; Kim SH
    Neurobiol Aging; 2014 May; 35(5):1213.e13-7. PubMed ID: 24387985
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cerebrospinal fluid soluble TREM2 levels in frontotemporal dementia differ by genetic and pathological subgroup.
    Woollacott IOC; Nicholas JM; Heslegrave A; Heller C; Foiani MS; Dick KM; Russell LL; Paterson RW; Keshavan A; Fox NC; Warren JD; Schott JM; Zetterberg H; Rohrer JD
    Alzheimers Res Ther; 2018 Aug; 10(1):79. PubMed ID: 30111356
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genetic Features of MAPT, GRN, C9orf72 and CHCHD10 Gene Mutations in Chinese Patients with Frontotemporal Dementia.
    Che XQ; Zhao QH; Huang Y; Li X; Ren RJ; Chen SD; Wang G; Guo QH
    Curr Alzheimer Res; 2017; 14(10):1102-1108. PubMed ID: 28462717
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Phenotype variability in progranulin mutation carriers: a clinical, neuropsychological, imaging and genetic study.
    Le Ber I; Camuzat A; Hannequin D; Pasquier F; Guedj E; Rovelet-Lecrux A; Hahn-Barma V; van der Zee J; Clot F; Bakchine S; Puel M; Ghanim M; Lacomblez L; Mikol J; Deramecourt V; Lejeune P; de la Sayette V; Belliard S; Vercelletto M; Meyrignac C; Van Broeckhoven C; Lambert JC; Verpillat P; Campion D; Habert MO; Dubois B; Brice A;
    Brain; 2008 Mar; 131(Pt 3):732-46. PubMed ID: 18245784
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Distinct clinical and pathological phenotypes in frontotemporal dementia associated with MAPT, PGRN and C9orf72 mutations.
    Snowden JS; Adams J; Harris J; Thompson JC; Rollinson S; Richardson A; Jones M; Neary D; Mann DM; Pickering-Brown S
    Amyotroph Lateral Scler Frontotemporal Degener; 2015; 16(7-8):497-505. PubMed ID: 26473392
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cerebrospinal Fluid YKL-40 and Chitotriosidase Levels in Frontotemporal Dementia Vary by Clinical, Genetic and Pathological Subtype.
    Woollacott IOC; Nicholas JM; Heller C; Foiani MS; Moore KM; Russell LL; Paterson RW; Keshavan A; Schott JM; Warren JD; Heslegrave A; Zetterberg H; Rohrer JD
    Dement Geriatr Cogn Disord; 2020; 49(1):56-76. PubMed ID: 32344399
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cerebral blood flow in presymptomatic MAPT and GRN mutation carriers: A longitudinal arterial spin labeling study.
    Dopper EG; Chalos V; Ghariq E; den Heijer T; Hafkemeijer A; Jiskoot LC; de Koning I; Seelaar H; van Minkelen R; van Osch MJ; Rombouts SA; van Swieten JC
    Neuroimage Clin; 2016; 12():460-5. PubMed ID: 27625986
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Thalamic atrophy in frontotemporal dementia - Not just a
    Bocchetta M; Gordon E; Cardoso MJ; Modat M; Ourselin S; Warren JD; Rohrer JD
    Neuroimage Clin; 2018; 18():675-681. PubMed ID: 29876259
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Frontotemporal dementia-related gene mutations in clinical dementia patients from a Chinese population.
    Shi Z; Liu S; Xiang L; Wang Y; Liu M; Liu S; Han T; Zhou Y; Wang J; Cai L; Gao S; Ji Y
    J Hum Genet; 2016 Dec; 61(12):1003-1008. PubMed ID: 27439681
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genetics of Frontotemporal Dementia.
    Olszewska DA; Lonergan R; Fallon EM; Lynch T
    Curr Neurol Neurosci Rep; 2016 Dec; 16(12):107. PubMed ID: 27878525
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Motor Speech Phenotypes of Frontotemporal Dementia, Primary Progressive Aphasia, and Progressive Apraxia of Speech.
    Poole ML; Brodtmann A; Darby D; Vogel AP
    J Speech Lang Hear Res; 2017 Apr; 60(4):897-911. PubMed ID: 28289749
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mendelian forms of disease and age at onset affect survival in frontotemporal dementia.
    Cosseddu M; Benussi A; Gazzina S; Turrone R; Archetti S; Bonomi E; Biasiotto G; Zanella I; Ferrari R; Cotelli MS; Alberici A; Padovani A; Borroni B
    Amyotroph Lateral Scler Frontotemporal Degener; 2018 Feb; 19(1-2):87-92. PubMed ID: 28990425
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genetic screen in a large series of patients with primary progressive aphasia.
    Ramos EM; Dokuru DR; Van Berlo V; Wojta K; Wang Q; Huang AY; Miller ZA; Karydas AM; Bigio EH; Rogalski E; Weintraub S; Rader B; Miller BL; Gorno-Tempini ML; Mesulam MM; Coppola G
    Alzheimers Dement; 2019 Apr; 15(4):553-560. PubMed ID: 30599136
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A novel frameshift GRN mutation results in frontotemporal lobar degeneration with a distinct clinical phenotype in two siblings: case report and literature review.
    Hosaka T; Ishii K; Miura T; Mezaki N; Kasuga K; Ikeuchi T; Tamaoka A
    BMC Neurol; 2017 Sep; 17(1):182. PubMed ID: 28915852
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.